Loading

Mucous Membrane Pemphigoid: A Review

Mini Review | Open Access | Volume 8 | Issue 2

  • 1. Department of Dermatology, University of Limoges, France
+ Show More - Show Less
Corresponding Authors
Christophe Bédane, Department of Dermatology, University of Limoges, France,
Abstract

Mucous membrane pemphigoid (MMP) belongs to the group of subepidermal blistering diseases and refers to a subgroup characterized by predominant mucosal involvement. Various target antigens are involved within the basement membrane zone.

Citation

Bédane C (2020) Mucous Membrane Pemphigoid: A Review. J Dermatolog Clin Res 8(2): 1132.

INTRODUCTION

Mucous membrane pemphigoid (MMP) belongs to the group of sub epidermal blistering diseases and refers to a subgroup characterized by predominant mucosal involvement. Various target antigens are involved within the basement membrane zone. The average Annual incidence isestimated to be 1/500,000 to 1/770,000 in western countries and is regularly increasing. A slight male predominance is reported. In most cases, the treatment is based anti-inflammatory drugs (corticosteroids, dapsone or sulfasalazin) in association to immunosuppressants (ciclophosphamid, mycophenolatemofetil (MMF)). Rituximab and etanercept have also been proposed for resistant MMP but need further evaluations [1,2]. MMF is theoretically a treatment of choice due to its good long term tolerance and efficacy especially in the elderly patients.

CLINICAL DESCRIPTION

The averageage of onsetis 60-70 years. The median age at diagnosis in our center is 78 years The average time for diagnosisis 28 months [1].

The diseaseis rare in children. Mucous membrane pemphigoidis a chronic disease with periods of more rapid evolution. The disease manifests as fragile bullous lesions that give way to superficial erosions. The principle sites affected are the oral (80-90% of cases), ocular (50-70% of cases), pharyngolaryngeal (8-20% of cases), genital (15% of cases) and esophageal mucous membranes. Someforms affect only one mucosal membrane, in particular the buccal (erosive gingivitis) or ocular mucosae. An exclusively cutaneous form has also been observed in some cases. The ocular manifestations are initially inflammatory but then lead to retractile scarring of the conjunctive membrane, associated with corneal metaplasia resulting in vision loss.

PHYSIOPATHOLOGY AND DIAGNOSTIC TOOLS

The main antigens are the C term portion of collagen 17 and laminin 332 Whilst the etiology is unknown, several different antigens are implicated in the autoantibody response including BPAg1, BPAg2, integrin subunits alpha-6/beta-4, laminin 5 and 6, and type VII collagen.

Immunological Studies Reveal the presence of auto-anti- bodies against several antigens such as PB180, the alpha Lam- inin-5 subunit and the beta subunit of the integrin alpha-6 beta-4 complex. Histologically, the cutaneous or mucosal blisters are subepithelial, without evidence of acantholysis, and are indis- tinguishable from those of bullous pemphigoid. Diagnosis can be confirmed by direct (DIF) or indirect immunofluorescence analy- sis.unoelectronmicroscopycandifferentiatebullousfromcicatric- ialpemphigoid by the precise location of immune depositsalong the basement membrane. Immune deposits in MMP are located deeper than in bullous pemphigoid where they are restricted to the hemidesmosomal area [2].

DIFFERENTIAL DIAGNOSIS

Differential diagnosis includes the full range of autoimmune bullous disorders. Pemphigus vulgaris is differentiated by the DIF pattern with a labelling of the intercellular substance. Bul- lous pemphigoid is characterized by a predominant cutaneous involvement. Epidermolysis bullosa acquisita is a difficult to differentiate and relies on ELISA (enzyme-linked immunosorb- ent assay) anti collagene VII, a different localization of immune depositsalong the basement membrane zone as imaged by im- munoelectron microscopy, or DIF on salt separated skin. Oral erosive lichen planus and recurrenta phtosis do not show any im- mune deposits on DIF.

MANAGEMENT AND TREATMENT

Management should be multidisciplinary with close follow- up in specialized center, in particular for the management of the ocular manifestations. The choice of therapeutic strategy (anti- inflammatorydrugs, immunosuppressive therapy, intravenous immunoglobulin or local treatments) depends in the severity of the oculardisease.

Dapsoneis the reference treatment for MMP with response rates of 50 to 80% in monotherapy [3] (Rogers 1988). The oral and inflammatory subypes of MMP are the best responder to dapsone [4].

There are 10-25% of adverse events and agranulocytosis can occur (1/400 at the beginning of treatment) sulfasalazine or cy- clines car serve as alternative optoiions in patients intolerant to dapsone

Mycophénolatemofétil (MMF) is an inhibitor of purine syn- thesis and targets B and T Lymphocytes. MMF can be considered as the reference immunosuppressive drugs for the management of MMP and related disorders MMF is more efficient thancy- closprine and less toxic than cyclophosphamide. MMP score im- provement ranges from 60 to 85% for inflammation andocular pain .A control of the disease can be obtained for up to 80 % of patients [5-7].

The optimization of MMF dose is efficient for refractory pa- tients we have recently demonstrated in 8 patients with 15 ad- justements that the the median AUC before Treatmentwas 36 mg.h/l whereas the therapeutic objective was 45-50 mg.h/l. In most patients the adjustement has led to a better control of the disease (unpublished results)

Rituximabhas been proposed for patients with refractory MMP. Most patients are now treated with the auto immune regi- mentwo cycles of 1000mg Two weeks apart. The clinical benefit of the treatment occurs within 12 weeks with 86% of controm of the disease [8]. Long term remissions seems more questionable and it seems that a maintenance treatment is necessary in de- crease of 40% the relapse risk Oesophagal involvement should be carefully monitored in patients withsevere oral involvement and can be found in 10 to 40% of MMP patients whereas they present with clinical symptoms or not [9].

Ocular inflammation leading to corneal involvement with symblepharon and corneal opacification with a progressive risk of blindnessis one of the major goals for the treatment of ocular MMP. Manystudies have demonstrated that MMF allowed good control of ocular inflammation in 60 to70% of patients. We have treated 18 patients with ocular MMPwitha control of 81% of ocu- lar inflammation. The combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid may help to increases the control of inflammation [10].

Topical treatment plays a major role for MMP control.

Antisepsy and topical corticosteroids may help to control oral involvement.

Ocular inflammation control is also improved by artificial tears antisepticeye drops vitamin B and regular ablation of en- tropion is eyelashes with the use of sclerallens.

Interferon or cyclosporine eye drops have been proposed to improve ocular MMP.

PROGNOSIS

The prognosis also revolves around the ocular manifesta- tions, which may lead to blindness due to scarring of the conjunc- tive membrane and corneal metaplasia.

REFERENCES
  1. Bedane C, Doffoel V. Mucous membrane pemphigoid: a review. Ann Dermatol Venereol. 2011; 138: 201-208.
  2. Bedane C, Prost C, Bernard P, Catanzano G, Bonnetblanc JM, Duber- tret L. Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immune electron microscopy. J Invest Dermatol. 1991; 97: 3-9.
  3. Rogers RS, Mehregan DA. Dapsone therapy of cicatricial pemphigoid Semin Dermatol. 1988; 7: 201-205.
  4. Ciarroca K, Greenberg M. A retrospective study of the management of oral mucous membrane pemphigoid with dapsone Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88: 159-163.
  5. Doffoel-HantzV, Robert, Bédane PYC. Cicatricial pemphigoid, mucous membrane pemphigoid Presse Med. 2010; 39: 1045-1049.
  6. Ingen-Housz-Oro, Prost CS, Pascal F, Doan S, Brette MD, Bachelez H, et al. Cicatricial pemphigoid: treatment with mycophenolate mofetil. Ann Dermatol Venereol. 2005; 132: 13-16.
  7. Nottage J, Hammersmith K, Murchison AP. Treatment of mucous membrane pemphigoid with mycophenolate mofetil Cornea. 2013; 32: 810-815.
  8. Le Roux-Villet C, Prost-Squarcioni C, Alexandre M, Caux F, Pascal F, Doan S, et al. Rituximab for patients with refractorymucous mem- brane pemphigoid Arch Dermatol. 2011; 147: 843-849.
  9. Maglie R, Borgi A, Caproni M. Indirect immunofluorescence in mucous membrane pemphigoid: which substrate should be used? Br J Derma- tol. 2019; 180: 1266-1267.
  10. Steger B, Madhusudan S, Kaye S, Stylianides A, Romano V, Maqsood SE, et al. Combined Use of Rituximab and Intravenous Immunoglobulin for Severe Autoimmune Cicatricial Conjunctivitis-An Interventional Case Series. Cornea. 2016; 35: 1611-1614.

Bédane C (2020) Mucous Membrane Pemphigoid: A Review. J Dermatolog Clin Res 8(2): 1132.

Received : 29 Jul 2020
Accepted : 13 Aug 2020
Published : 15 Aug 2020
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X